TAU Opioid Use Outcomes Following Discharge From Detoxification and Short Term Residential Programs Affiliated With CTN-0051

Exclusion Criteria

• •Serious medical, psychiatric or substance use disorder that, in the opinion of the Site PI, would make participation hazardous to the participant, compromise study findings or prevent the participant from completing the study;
• •Suicidal or homicidal ideation that requires immediate attention;
• •Maintenance on methadone at doses of 30mg or greater at the time of signing consent;
• •Presence of pain of sufficient severity as to require ongoing pain management with opioids;
• •Pending legal action or other reasons that might prevent an individual from completing the study;
• •If female, currently pregnant or breastfeeding or planning on conception;
• •Prior participation in parent trial CTN-0051